SUD / rehabCoverage & appeals · ASAM level of care & parity

Substance-use treatment denial: how to appeal a rehab or detox denial

Addiction-treatment denials are level-of-care denials in disguise: the plan says a less intensive setting fits. The ASAM Criteria are the language that argument is won or lost in.

Substance-use treatment denials — detox, residential rehab, intensive outpatient — usually turn on level of care and medical necessity. The ASAM Criteria are the widely used clinical standard for matching a patient to the right level. Denials are frequently appealable when the record shows the patient met the ASAM dimensions for the level provided, with parity reinforcing the case.

How substance-use treatment is covered

Coverage depends on medical necessity and the appropriate ASAM level of care, assessed across dimensions such as withdrawal risk, biomedical and psychiatric conditions, and the recovery environment. Parity (MHPAEA) means a plan's authorization and level-of-care rules for addiction treatment can't be more restrictive than comparable medical/surgical rules; some states also require generally accepted standards by law.

Why substance-use treatment claims get denied

  • Level of care “too high” under the plan's reading of the ASAM dimensions.
  • Concurrent review ended the stay before continued-stay criteria were met.
  • Detox or residential admission criteria not documented to the standard.
  • Prior authorization missing or incomplete.
  • Out-of-network facility.

Is a substance-use treatment denial worth appealing?

Sometimes worth appealing

Often worth appealing: build the case on the ASAM dimensions, showing the patient met the criteria for the level provided and that a lower level couldn't safely manage withdrawal risk or co-occurring conditions. Raise parity and request the NQTL comparative analysis. As with all behavioral-health appeals, the federal duty to follow generally accepted standards is unsettled after Wit, so document thoroughly and use state law where it strengthens the case.

How to appeal a substance-use treatment denial

  1. 1

    Argue the ASAM dimensions explicitly

    Walk through the ASAM dimensions — withdrawal, biomedical, emotional/behavioral, readiness, relapse risk, recovery environment — and show how the record supports the level provided.

  2. 2

    Counter a length-of-stay cut

    For a concurrent-review denial, document that continued-stay criteria were still met on the date coverage stopped.

  3. 3

    Use parity and external review

    Request the NQTL comparative analysis and, if the internal appeal fails, take it to an independent external review; ERISA governs self-funded plans.

substance-use treatment — frequently asked

What are the ASAM Criteria?
A widely used clinical framework that matches a patient to the appropriate level of addiction care across several dimensions (withdrawal risk, co-occurring conditions, recovery environment, and more). Most appeals are won or lost on these dimensions.
Is a shortened rehab stay appealable?
Yes. Appeal the concurrent-review denial by documenting that continued-stay criteria under ASAM were still met when coverage was stopped, and escalate to external review if necessary.

FDA-approved indications and payer prior-authorization criteria are paraphrased for plain-language reference, not reproduced verbatim, and vary by plan. This is general information, not medical, legal, or coverage advice — confirm against the current FDA label, the plan's policy, and the patient's benefit documents.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.